Pages that link to "Q37475959"
Jump to navigation
Jump to search
The following pages link to Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis (Q37475959):
Displaying 50 items.
- Mucormycosis, pseudallescheriasis, and other uncommon mold infections (Q24603297) (← links)
- Recent advances in the management of mucormycosis: from bench to bedside (Q24642450) (← links)
- Fungal infections of the orbit (Q26744426) (← links)
- Invasive mold infections in solid organ transplant recipients (Q26823811) (← links)
- Mucormycosis in a renal transplant recipient: case report and comprehensive review of literature (Q26860727) (← links)
- Recent developments in the management of invasive fungal infections in patients with oncohematological diseases (Q28077381) (← links)
- Biology, systematics, and clinical manifestations of Zygomycota infections (Q28656453) (← links)
- Mucormycosis in Iran: a systematic review. (Q30251882) (← links)
- Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). (Q30608976) (← links)
- Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data (Q30873926) (← links)
- Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data (Q33384785) (← links)
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (Q33573788) (← links)
- Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole. (Q33633913) (← links)
- Fungal Orbital Cellulitis: Presenting Features, Management and Outcomes at a Referral Center (Q33783822) (← links)
- Pulmonary mucormycosis: what is the best strategy for therapy? (Q33790609) (← links)
- The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. (Q33882951) (← links)
- Fungal infections in transplant and oncology patients (Q33896940) (← links)
- The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis (Q34017347) (← links)
- Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients. (Q34151170) (← links)
- Recent Advances in the Treatment of Mucormycosis (Q34161213) (← links)
- Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoter (Q34315804) (← links)
- Rhinocerebral mucormycosis in a diabetic case report (Q34495802) (← links)
- Combat-Related Invasive Fungal Wound Infections (Q34708588) (← links)
- Zygomycosis in Immunocompromised non-Haematological Patients. (Q35010681) (← links)
- Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis (Q35065748) (← links)
- How should we manage a patient with invasive mucoromycosis who develops life-threatening reaction to amphotericin B? Report of two cases and literature review (Q35196776) (← links)
- Human Fungal Pathogens of Mucorales and Entomophthorales (Q35245238) (← links)
- Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009 (Q35364288) (← links)
- Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients (Q35666527) (← links)
- How I treat mucormycosis (Q35797637) (← links)
- Actinomucor elegans as an emerging cause of Mucormycosis. (Q35806858) (← links)
- Combination therapy for mucormycosis: why, what, and how? (Q35974333) (← links)
- Gastrointestinal Mucormycosis following a Streptococcus pyogenes Toxic Shock Syndrome in a Previously Healthy Patient: A Case Report (Q36147953) (← links)
- Utility of frozen section analysis for fungal organisms in soft tissue wound debridement margin determination (Q36169074) (← links)
- Combination Antifungal Therapy: A Review of Current Data (Q36369805) (← links)
- Orbital mucormycosis in an immunocompetent individual. (Q36425955) (← links)
- Invasive fungal infections in acute leukemia (Q36612597) (← links)
- Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). (Q36862446) (← links)
- CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). (Q37041199) (← links)
- Fungal rhinosinusitis and imaging modalities (Q37060071) (← links)
- Therapeutic Challenges of Hepatic Mucormycosis in Hematologic Malignancy: A Case Report and Review of the Literature. (Q37103298) (← links)
- In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. (Q37274705) (← links)
- Mucormycosis in two community hospitals and the role of infectious disease consultation: a case series (Q37278607) (← links)
- Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis (Q37312187) (← links)
- Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment (Q37315227) (← links)
- Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report (Q37380610) (← links)
- Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update (Q37421528) (← links)
- Invasive mold infections: recent advances in management approaches (Q37428946) (← links)
- Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). (Q37469829) (← links)
- Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? (Q37475459) (← links)